Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-10

Clinical Trial Update: Transcutaneous Vagus Nerve Stimulation for the Treatment of Lupus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating transcutaneous vagus nerve stimulation for systemic lupus erythematosus was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Aikaterini Thanou | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: TERMINATED | Results posted: 2019-10-10